HIV/AIDS

Data, statistics and information regarding HIV/AIDS related to injection drug use

AIDS Diagnoses by Gender and Transmission Method, 2007

(AIDS Diagnoses by Gender and Transmission Method, 2007) "Of the estimated 398,057 male adults and adolescents living with HIV/AIDS, 64% had been exposed through male-to-male sexual contact, 16% through injection drug use, 12% through high-risk heterosexual contact, and 7% through both male-to-male sexual contact and injection drug use. Of the estimated 146,692 female adults and adolescents living with HIV/ AIDS, 72% had been exposed through high-risk heterosexual contact, and 26% had been exposed through injection drug use."

Estimated Worldwide Number of People Who Inject Drugs

"The UNODC/WHO/UNAIDS/World Bank joint estimate of the number of PWID in 2016 is 10.6 million (range: 8.3 million to 14.7 million), corresponding to 0.22 per cent (range: 0.17 to 0.30 per cent) of the global population aged 15–64 years. This estimate is based on the most recent and highest quality information currently available to UNODC. It does not imply that there has been a change in the global number of PWID compared with those published in previous editions of the World Drug Report.

Estimated Prevalence of People Who Inject Drugs (PWID) in the US

"Overall, the number of PWID per 10,000 persons aged 15–64 years varied from 31 to 345 across MSAs [Metropolitan Statistical Areas], median 104.4 (mean 127.4; standard deviation 66.7; percentile range 76–162) in 1992 and from 34 to 324 across MSAs, median 91.5 (mean 103.6; standard deviation 56.4; percentile range 61–125 ) in 2007 indicating an overall decline in PWID prevalence across MSAs.

Number of HIV and AIDS Diagnoses and Deaths in the US

Number of HIV and AIDS Diagnoses and Deaths in the US: "CDC estimates that more than 1.1 million people in the United States (US) are living with HIV infection. Nearly one in five (18.1%) of those people are unaware of their infection. Despite increases in the total number of people in the US living with HIV infection in recent years (due to better testing and treatment options), the annual number of new HIV infections has remained relatively stable.

Cost Effectiveness of Harm Reduction

"Prevention of HIV is also cheaper than treatment of HIV/AIDS. For example, in Asia it is estimated that the comprehensive package of HIV-related harm reduction interventions costs $39 per disability-adjusted life-year saved,14 whereas antiretroviral treatment costs approximately $2,000 per life-year saved. Such figures demonstrate that harm reduction is a low-cost, high-impact intervention."

Pages